Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Enrique Chacon-Cruz, Erika Zoe Lopatynsky-Reyes, Gloria Huerta-Garcia, Maria Yolanda Cervantes-Apolinar, Adriana Guzman-Holst & Desiree Van Oorschot. (2022) Economic burden of meningococcal disease in children and adolescents in Tijuana, Mexico. Human Vaccines & Immunotherapeutics 18:6.
Read now
Read now
Luis Román Ramírez-Palacios, Diana Reséndez-Pérez, Maria Cristina Rodríguez-Padilla, Santiago Saavedra-Alonso, Olga Real-Najarro, Nadia A Fernández-Santos & Mario A Rodriguez Perez. (2018) Molecular diagnosis of microbial copathogens with influenza A(H1N1)pdm09 in Oaxaca, Mexico. Research and Reports in Tropical Medicine 9, pages 49-62.
Read now
Read now
Xavier Sáez-Llorens, Johnny Beltran-Rodriguez, Jose M. Novoa Pizarro, Ilhem Mensi, Pavitra Keshavan & Daniela Toneatto. (2018) Four-year antibody persistence and response to a booster dose of a pentavalent MenABCWY vaccine administered to healthy adolescents and young adults. Human Vaccines & Immunotherapeutics 14:5, pages 1161-1174.
Read now
Read now
Rouba Shaker, Danielle Fayad & Ghassan Dbaibo. (2018) Challenges and opportunities for meningococcal vaccination in the developing world. Human Vaccines & Immunotherapeutics 14:5, pages 1084-1097.
Read now
Read now
Lara Evellyn do Macedo, Viviane Matos Ferreira, Caroline Alves Feitosa, Amélia Maria Pithon Borges Nunes, Leila Carvalho Campos & Marco Aurélio Palazzi Sáfadi. (2018) Impact of meningococcal C conjugate vaccination programs with and without catch-up campaigns in adolescents: Lessons learned from Bahia, Brazil. Human Vaccines & Immunotherapeutics 14:5, pages 1131-1137.
Read now
Read now
Aia Assaf-Casals & Ghassan Dbaibo. (2016) Meningococcal quadrivalent tetanus toxoid conjugate vaccine (MenACWY-TT, Nimenrix™): A review of its immunogenicity, safety, co-administration, and antibody persistence. Human Vaccines & Immunotherapeutics 12:7, pages 1825-1837.
Read now
Read now
Giannina Izquierdo, Juan Pablo Torres, M Elena Santolaya, M Teresa Valenzuela, Jeannette Vega & May Chomali. (2015) Cost-effectiveness analysis of a multicomponent meningococcal serogroup B vaccine in hypothetic epidemic situation in a middle-income country. Human Vaccines & Immunotherapeutics 11:4, pages 875-883.
Read now
Read now
Anne Abio, Keith R. Neal & Charles R. Beck. (2013) An epidemiological review of changes in meningococcal biology during the last 100 years. Pathogens and Global Health 107:7, pages 373-380.
Read now
Read now
Marco Aurélio P Sáfadi, Luz Elena Espinosa de los Monteros, Eduardo Luis López, Xavier Sàez-Llorens, Ana Paula Lemos, Sarbelio Moreno-Espinosa, Silvia González Ayala, Juan Pablo Torres, José Cassio de Moraes & Julio Alberto Vázquez. (2013) The current situation of meningococcal disease in Latin America and recommendations for a new case definition from the Global Meningococcal Initiative. Expert Review of Vaccines 12:8, pages 903-915.
Read now
Read now
Félix O Dickinson, Antonio E Pérez & Iván E Cuevas. (2012) Meningococcal disease serogroup C. Risk Management and Healthcare Policy 5, pages 1-15.
Read now
Read now
Seon Hee Shin & Kwang Sik Kim. (2012) Treatment of bacterial meningitis: an update. Expert Opinion on Pharmacotherapy 13:15, pages 2189-2206.
Read now
Read now
Ener Cagri Dinleyici & Mehmet Ceyhan. (2012) The dynamic and changing epidemiology of meningococcal disease at the country-based level: the experience in Turkey. Expert Review of Vaccines 11:5, pages 515-518.
Read now
Read now
Marco AP Sáfadi & E David G McIntosh. (2011) Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies. Expert Review of Vaccines 10:12, pages 1717-1730.
Read now
Read now
Rolando Ulloa-Gutierrez, Greta Miño, Carla Odio, María L Avila-Aguero & José Brea. (2011) Vaccine-preventable diseases and their impact on Latin American children. Expert Review of Vaccines 10:12, pages 1671-1673.
Read now
Read now
Articles from other publishers (44)
R. Menezes Martins, A.R.S. Périssé, L.A.B. Camacho, M.L. Leal, M.L.S. Maia, A. Homma & E. Jessouroun. (2021) Phase I safety and immunogenicity study of a Brazilian serogroup B vaccine. The Brazilian Journal of Infectious Diseases 25:6, pages 101652.
Crossref
Crossref
Mercedes Macias Parra, Isabel Medina-Vera, Eduardo Arias De la Garza, Miguel A. Rodriguez Weber & Ximena León-Lara. (2021) The Impact of Haemophilus Influenzae and Streptococcus Pneumoniae Vaccination in Bacterial Meningitis in a Pediatric Referral Hospital in Mexico. Journal of Pediatric Infectious Diseases 16:05, pages 230-236.
Crossref
Crossref
Yih-Ling Tzeng & David S. Stephens. (2021) A Narrative Review of the W, X, Y, E, and NG of Meningococcal Disease: Emerging Capsular Groups, Pathotypes, and Global Control. Microorganisms 9:3, pages 519.
Crossref
Crossref
Nabila Monalisa Mendes Dantas Sales, Jailton Azevedo, Marcelo Teles Bastos Ribeiro, Humberto Fonseca de Freitas, Hermes Pedreira da Silva Filho, Soraia Machado Cordeiro, Mitermayer Galvão Reis & Joice Neves Reis. (2020) Long-term impacts of MenC vaccination campaign in the Salvador, Brazil metropolitan region: A comparison of pre- and post-vaccine periods. Vaccine 38:40, pages 6267-6273.
Crossref
Crossref
Ricardo Becker Feijo & Juarez Cunha. (2020) Trajectory of serogroups causing Invasive Meningococcal Disease in Santa Catarina state, Brazil (2007–2019). The Brazilian Journal of Infectious Diseases 24:4, pages 349-351.
Crossref
Crossref
Rahel Maria Kindler, Marc Kuster & Doris Madörin. (2019) Tod innerhalb von Stunden. Praxis 108:13, pages 877-882.
Crossref
Crossref
Jéssica Vespa Presa, Maria Gabriela Abalos, Rodrigo Sini de Almeida & Alejandro Cane. (2019) Epidemiological burden of meningococcal disease in Latin America: A systematic literature review. International Journal of Infectious Diseases 85, pages 37-48.
Crossref
Crossref
José Francisco Santos-Neto, Viviane Matos Ferreira, Caroline Alves Feitosa, Martha Silvia Martinez-Silveira & Leila Carvalho Campos. (2019) Carriage prevalence of Neisseria meningitidis in the Americas in the 21st century: a systematic review. The Brazilian Journal of Infectious Diseases 23:4, pages 254-267.
Crossref
Crossref
J. A. Gómez, P. Wetzler Malbrán, G. Vidal, M. Seoane & N. D. Giglio. (2019) Estimation of the real burden of invasive meningococcal disease in Argentina. Epidemiology and Infection 147.
Crossref
Crossref
Liliane C. Conteville, Ana Maria B. de Filippis, Rita Maria R. Nogueira, Marcos César L. de Mendonça & Ana Carolina P. Vicente. (2018) Metagenomics in undiagnosed cases of fulminant fever. Journal of Infection 77:2, pages 158-164.
Crossref
Crossref
Bingqing Zhu, Fenglin Shi, Aiyu Zhang, Xiaofang Sun, Zheng Xu, Li Xu, Yuan Gao, Jing Lv & Zhujun Shao. (2018) Prevalence and genetic characteristics of 4CMenB and rLP2086 vaccine candidates among Neisseria meningitidis serogroup B strains, China. Vaccine 36:15, pages 1983-1989.
Crossref
Crossref
Xuemeng Ji, Ping-Ping Yao, Le-Yi Zhang, Yi Li, Fang Xu, Ling-Ling Mei, Shui-Rong Zhu, Yan-Jun Zhang, Han-Ping Zhu & Stijn van der Veen. (2017) Capsule switching of Neisseria meningitidis sequence type 7 serogroup A to serogroup X. Journal of Infection 75:6, pages 521-531.
Crossref
Crossref
Lily Yin Weckx, Rosana Fiorini Puccini, Antónia Machado, Maria Gisele Gonçalves, Suely Tuboi, Eliana de Barros, Raghavendra Devadiga, Eduardo Ortega-Barria & Romulo Colindres. (2017) A cross-sectional study assessing the pharyngeal carriage of Neisseria meningitidis in subjects aged 1–24 years in the city of Embu das Artes, São Paulo, Brazil. The Brazilian Journal of Infectious Diseases 21:6, pages 587-595.
Crossref
Crossref
Rodrigo Siqueira Batista, Andréia Patrícia Gomes, Jorge Luiz Dutra Gazineo, Paulo Sérgio Balbino Miguel, Luiz Alberto Santana, Lisa Oliveira & Mauro Geller. (2017) Meningococcal disease, a clinical and epidemiological review. Asian Pacific Journal of Tropical Medicine 10:11, pages 1019-1029.
Crossref
Crossref
D.A. Cabrera-Gaytán, G.F. Pérez-Pérez, L. Arriaga-Nieto, A. Vallejos-Parás, R. Padilla-Velázquez & C. Grajales-Muñiz. (2017) Epidemiological surveillance of meningeal and encephalic syndrome in the Mexican Social Security Institute, 2012–2014. Revista Médica del Hospital General de México 80:3, pages 130-138.
Crossref
Crossref
Ángela Gentile, Julia Bakir, María Rosa Agosti, Gabriela Ensinck, Hector Abate, Andrea Gajo Gane, Alejandro Santillán Iturres, Adriana Efron, Mabel Regueira & Ricardo Rüttimann. (2017) Meningococcal Disease in Children in Argentina A 3-year Active Sentinel Hospital Surveillance Study. Pediatric Infectious Disease Journal 36:3, pages 296-300.
Crossref
Crossref
Yaowen Zhang, Dong Wei, Xinzhen Guo, Mai Han, Lichao Yuan & Moe H Kyaw. (2016) Burden of Neisseria meningitidis infections in China: a systematic review and meta–analysis. Journal of Global Health 6:2.
Crossref
Crossref
Wânia F. Pereira-Manfro, Raquel M. Alvino, Aline C. Cruz, Giselle P. Silva, Raquel B.N. Castro, Bianca Ferreira, Daniella M. Barreto, Ana Cristina C. Frota, Cristina B. Hofer & Lucimar G. Milagres. (2016) Association of serum bactericidal antibody and opsonic antibody levels after Neisseria meningitidis serogroup C conjugate vaccine in Brazilian children and adolescents infected or not infected with HIV. Vaccine 34:50, pages 6116-6119.
Crossref
Crossref
Vanessa L. Strelow, Érique José F. Peixoto de Miranda, Karin R. Kolbe, Juliana V. Souza Framil, Augusto Penalva de Oliveira & José E. Vidal. (2016) Meningococcal meningitis: clinical and laboratorial characteristics, fatality rate and variables associated with in-hospital mortality. Arquivos de Neuro-Psiquiatria 74:11, pages 875-880.
Crossref
Crossref
Juan Manuel Gómez Muñoz, Julio César Gómez Rincón, Abraham Alí Munive, Carlos A. Cano Gutierrez, Paola X. Coral Alvarado, Wilfrido Coronell Rodríguez, Jorge Cortés Luna, Mónica Duarte Romero, Natalia Londoño Palacio, Ivette Maldonado Chaya, Ana Cristina Palacio Eastman & Alexandra Porras Ramirez. (2016) Guías para la inmunización del adolescente y adulto en Colombia. Documento de actualización, 2016. Infectio 20:4, pages 192-210.
Crossref
Crossref
Rosália Garcia Neves, Andrea Wendt Böhm, Caroline dos Santos Costa, Thaynã Ramos Flores, Ana Luiza Gonçalves Soares & Fernando César Wehrmeister. (2016) Cobertura da vacina meningocócica C nos estados e regiões do Brasil em 2012. Revista Brasileira de Medicina de Família e Comunidade 11:38, pages 1-10.
Crossref
Crossref
Helen Marshall, Bing Wang, Steve Wesselingh, Matthew Snape & Andrew J. Pollard. (2016) Control of invasive meningococcal disease. International Journal of Evidence-Based Healthcare 14:1, pages 3-14.
Crossref
Crossref
Alberto Velez-van-Meerbeke, Nicolás Medina-Silva, Sandra Besada-Lombana & José Alejandro Mojica-Madero. (2016) Epidemiología de la enfermedad por meningococo en Colombia. Infectio.
Crossref
Crossref
Enrique Chacon-Cruz, Cesar Adrian Martinez-Longoria, Eduardo Llausas-Magana, Antonio Luevanos-Velazquez, Jorge Alejandro Vazquez-Narvaez, Sandra Beltran, Ana Elena Limon-Rojas, Fernando Urtiz-Jeronimo, Jose Luis Castaneda-Narvaez, Francisco Otero-Mendoza, Fernando Aguilar-Del Real, Jesus Rodriguez-Chagoyan, Rosa Maria Rivas-Landeros, Maria Luisa Volker-Soberanes, Rosa Maria Hinojosa-Robles, Patricia Arzate-Barbosa, Laura Karina Aviles-Benitez, Fernando Ivan Elenes-Zamora, Chandra M. Becka & Ricardo Ruttimann. (2016)
Neisseria meningitidis
and
Streptococcus pneumoniae
as leading causes of pediatric bacterial meningitis in nine Mexican hospitals following 3 years of active surveillance
. Therapeutic Advances in Vaccines 4:1-2, pages 15-19.
Crossref
Crossref
Marco Aurélio P. Sáfadi, Miguel O’Ryan, Maria Teresa Valenzuela Bravo, Maria Cristina C. Brandileone, Maria Cecília O. Gorla, Ana Paula S. de Lemos, Gabriela Moreno, Julio A. Vazquez, Eduardo L. López, Muhamed-Kheir Taha & Ray Borrow. (2015) The current situation of meningococcal disease in Latin America and updated Global Meningococcal Initiative (GMI) recommendations. Vaccine 33:48, pages 6529-6536.
Crossref
Crossref
Kirsten P. Perrett, Jodie McVernon, Peter C. Richmond, Helen Marshall, Michael Nissen, Allison August, Sandra Percell, Daniela Toneatto & Terry Nolan. (2015) Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: A phase III, randomized, multicentre, lot-to-lot consistency study. Vaccine 33:39, pages 5217-5224.
Crossref
Crossref
Renata Chagas Bastos, Iaralice Medeiros de Souza, Milton Neto da Silva, Flavia de Paiva Silva, Elza Scott Figueira, Maria de Lurdes Leal, Ellen Jessouroun, José Godinho da Silva Junior, Ricardo de Andrade Medronho & Ivna Alana Freitas Brasileiro da Silveira. (2015) Brazilian meningococcal C conjugate vaccine: Scaling up studies. Vaccine 33:35, pages 4281-4287.
Crossref
Crossref
Márcia de Cantuária Tauil, Cleidiane Santos Rodrigues de Carvalho, Ataiza César Vieira & Eliseu Alves Waldman. (2014) Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil. The Brazilian Journal of Infectious Diseases 18:4, pages 379-386.
Crossref
Crossref
Enrique Chacon-Cruz, Luz Elena Espinosa-De Los Monteros, Samuel Navarro-Alvarez, Jose Luis Aranda-Lozano, Maria Luisa Volker-Soberanes, Rosa Maria Rivas-Landeros, Ariadna Annete Alvelais-Arzamendi & Julio Alberto Vazquez. (2014) An outbreak of serogroup C (ST-11) meningococcal disease in Tijuana, Mexico. Therapeutic Advances in Vaccines 2:3, pages 71-76.
Crossref
Crossref
Ricardo Walter Rüttimann, Angela Gentile, Mercedes Macias Parra, Xavier Saez-Llorens, Marco Aurelio Palazzi Safadi & Maria Elena Santolaya. (2014) A Consensus Statement. Pediatric Infectious Disease Journal 33:3, pages 284-290.
Crossref
Crossref
Rabab Z Jafri, Asad Ali, Nancy E Messonnier, Carol Tevi-Benissan, David Durrheim, Juhani Eskola, Florence Fermon, Keith P Klugman, Mary Ramsay, Samba Sow, Shao Zhujun, Zulfiqar A Bhutta & Jon Abramson. (2013) Global epidemiology of invasive meningococcal disease. Population Health Metrics 11:1.
Crossref
Crossref
Leonam G Coutinho, Denis Grandgirard, Stephen L Leib & Lucymara F Agnez-Lima. (2013) Cerebrospinal-fluid cytokine and chemokine profile in patients with pneumococcal and meningococcal meningitis. BMC Infectious Diseases 13:1.
Crossref
Crossref
Vanessa L. Strelow & Jose E. Vidal. (2013) Invasive meningococcal disease. Arquivos de Neuro-Psiquiatria 71:9B, pages 653-658.
Crossref
Crossref
M. A. P. SÁFADI, S. GONZÁLEZ-AYALA, A. JÄKEL, H. WIEFFER, C. MORENO & A. VYSE. (2012) The epidemiology of meningococcal disease in Latin America 1945–2010: an unpredictable and changing landscape. Epidemiology and Infection 141:3, pages 447-458.
Crossref
Crossref
Bernadete L. Liphaus, Maria Inês Cappeletti-Gonçalves-Okai, Ana Paula Silva-Delemos, Maria Cecília Gorla, Miriam Rodriguez-Fernandes, Márcia Regina Pacola, Maria Ângela Fernandez-Collucci, Iara Akemi Matsumoto-Shinkai, Fábio Takenori-Higa, Cleide Ferreira-Catani, Eneida Gonçalves-Lemes-Marques & Telma Regina Marques-Pinto-Carvalhanas. (2013) Outbreak of Neisseria meningitidis C in a Brazilian oil refinery involving an adjacent community. Enfermedades Infecciosas y Microbiología Clínica 31:2, pages 88-92.
Crossref
Crossref
James Wassil, E David G McIntosh, Davide Serruto, Lisa DeTora, Michael Bröker & Alan Kimura. (2012) The early clinical development of a multicomponent vaccine against meningococcal serogroup B. Clinical Investigation 2:5, pages 503-517.
Crossref
Crossref
Matthew J. Bottomley, Davide Serruto, Marco Aurélio Palazzi Sáfadi & Keith P. Klugman. (2012) Future challenges in the elimination of bacterial meningitis. Vaccine 30, pages B78-B86.
Crossref
Crossref
Brian Greenwood, Emiliano Chiarot, Calman A. MacLennan & Miguel O’Ryan. (2012) Can we defeat meningococcal disease in low and middle income countries?. Vaccine 30, pages B63-B66.
Crossref
Crossref
Scott A. Halperin, Julie A. Bettinger, Brian Greenwood, Lee H. Harrison, Jane Jelfs, Shamez N. Ladhani, Peter McIntyre, Mary E. Ramsay & Marco A.P. Sáfadi. (2012) The changing and dynamic epidemiology of meningococcal disease. Vaccine 30, pages B26-B36.
Crossref
Crossref
Nadine G. Rouphael & David S. Stephens. 2012. Neisseria meningitidis. Neisseria meningitidis
1
20
.
Patricia Coelho de Soarez, Ana Marli C. Sartori, Laura de Andrade Lagoa Nóbrega, Alexander Itria & Hillegonda Maria Dutilh Novaes. (2011) Cost-Effectiveness Analysis of a Universal Infant Immunization Program with Meningococcal C Conjugate Vaccine in Brazil. Value in Health 14:8, pages 1019-1027.
Crossref
Crossref
Kristina A. BryantGary S. MarshallColin D. MarchantNoris Pavia-RuizTerry NolanStephen RinderknechtMark Blatter, Emmanuel Aris, Pascal Lestrate, Dominique Boutriau, Leonard R. Friedland & Jacqueline M. Miller. (2011)
Immunogenicity and Safety of
H influenzae
Type b–
N meningitidis
C/Y Conjugate Vaccine in Infants
. Pediatrics 127:6, pages e1375-e1385.
Crossref
Crossref
Lee H. Harrison, Stephen I. Pelton, Annelies Wilder-Smith, Johan Holst, Marco A.P. Safadi, Julio A. Vazquez, Muhamed-Kheir Taha, F. Marc LaForce, Anne von Gottberg, Ray Borrow & Stanley A. Plotkin. (2011) The Global Meningococcal Initiative: Recommendations for reducing the global burden of meningococcal disease. Vaccine 29:18, pages 3363-3371.
Crossref
Crossref
Jaffar A. Al‐Tawfiq, Thomas A. Clark & Ziad A. Memish. (2010) Meningococcal Disease: The Organism, Clinical Presentation, and Worldwide Epidemiology. Journal of Travel Medicine 17:suppl 1, pages 3-8.
Crossref
Crossref